HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. uri icon

authors

  • Stephen L. Seliger, MD MS
  • Weiss, Noel S
  • Gillen, Daniel L
  • Kestenbaum, Bryan
  • Ball, Adrianne
  • Sherrard, Donald J
  • Stehman-Breen, Catherine O

publication date

  • January 2002